Ngā hua rapu - Nazzareno Galiè

Whakamahine hua
  1. 1
    The endothelin system in pulmonary arterial hypertension

    The endothelin system in pulmonary arterial hypertension mā Nazzareno Galiè

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Pulmonary hypertension in left heart disease

    Pulmonary hypertension in left heart disease mā Marco Guazzi, Nazzareno Galiè

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The role of the right ventricle in pulmonary arterial hypertension

    The role of the right ventricle in pulmonary arterial hypertension mā Anton Vonk Noordegraaf, Nazzareno Galiè

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era

    Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era mā Bradley A. Maron, Nazzareno Galiè

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The new clinical trials on pharmacological treatment in pulmonary arterial hypertension

    The new clinical trials on pharmacological treatment in pulmonary arterial hypertension mā Nazzareno Galiè, A. Mañes, Angelo Branzi

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses

    Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses mā Nazzareno Galiè, Massimiliano Palazzini, Alessandra Manes

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Pulmonary Arterial Hypertension: Combination Therapy in Practice

    Pulmonary Arterial Hypertension: Combination Therapy in Practice mā Marsha Burks, Simone Stickel, Nazzareno Galiè

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward

    Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward mā Edmund Lau, Alessandra Manes, David S. Celermajer, Nazzareno Galiè

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension

    PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension mā Nazzareno Galiè, Katharina Müller, Andrea‐Viviana Scalise, Ekkehard Grünig

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    End points in pulmonary arterial hypertension: the way forward

    End points in pulmonary arterial hypertension: the way forward mā Andrew J. Peacock, Robert Naeije, Nazzareno Galiè, John Τ. Reeves

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Liver toxicity of sitaxentan in pulmonary arterial hypertension

    Liver toxicity of sitaxentan in pulmonary arterial hypertension mā Nazzareno Galiè, Marius M. Hoeper, J. Simon, Richard Gibbs, Gérald Simonneau

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    An overview of the 6th World Symposium on Pulmonary Hypertension

    An overview of the 6th World Symposium on Pulmonary Hypertension mā Nazzareno Galiè, Vallerie V. McLaughlin, Lewis J. Rubin, Gérald Simonneau

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    A Novel Alu-Like Element Rearranged in the Dystrophin Gene Causes a Splicing Mutation in a Family with X-Linked Dilated Cardiomyopathy

    A Novel Alu-Like Element Rearranged in the Dystrophin Gene Causes a Splicing Mutation in a Family with X-Linked Dilated Cardiomyopathy mā Alessandra Ferlini, Nazzareno Galiè, Luciano Merlini, Caroline A. Sewry, Angelo Branzi, Francesco Muntoni

    I whakaputaina 1998
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona

    The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona mā Marc Humbert, Nazzareno Galiè, Lewis J. Rubin, Gérald Simonneau, Vallerie V. McLaughlin

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups

    Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups mā Alessandra Manes, Massimiliano Palazzini, Enri Leci, Maria Letizia Bacchi Reggiani, Angelo Branzi, Nazzareno Galiè

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Right heart thrombi in pulmonary embolism

    Right heart thrombi in pulmonary embolism mā Adam Torbicki, Nazzareno Galiè, Anna Covezzoli, Elisa Rossi, Marisa De Rosa, Samuel Z. Goldhaber

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

    A meta-analysis of randomized controlled trials in pulmonary arterial hypertension mā Nazzareno Galiè, A. Mañes, Luca Dal Negro, Massimiliano Palazzini, Maria Letizia Bacchi Reggiani, Angelo Branzi

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Pulmonary arterial hypertension: bridging the present to the future

    Pulmonary arterial hypertension: bridging the present to the future mā Marc Humbert, Rogério Souza, Nazzareno Galiè, Vallerie V. McLaughlin, Gérald Simonneau, Lewis J. Rubin

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil

    Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil mā R. J. Barst, Nazzareno Galiè, Robert Naeije, GÉRALD SIMONNEAU, Roger Jeffs, Carl Arneson, Leona J. Rubin

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

    Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease mā Ronald J. Oudiz, Robert Schilz, Robyn J. Barst, Nazzareno Galiè, Stuart Rich, Lewis J. Rubin, Gérald Simonneau

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: